Journal profile · IMMUNOLOGY-INFECTIOUS DISEASES
Journal of Microbiology Immunology and Infection
ISSN 1684-1182 · eISSN 1995-9133 · Elsevier Taiwan LLC · TAIWAN · Bimonthly · Founded 1998
Journal of Microbiology Immunology and Infection: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.72; fully open access; APC about USD 2,000; median 179 days to acceptance (113 articles, last 24 months); community-reported acceptance: about 95%; 134 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Microbiology Immunology and Infection is published by Elsevier Taiwan LLC and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Antibiotic Resistance in Bacteria, Antibiotic Use and Resistance and Pneumonia and Respiratory Infections, together about 22.9% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Microbiology, Immunology and Infection, launched in 1968, is the official bi-monthly publication of the Taiwan Society of Microbiology, the Chinese Society of Immunology, the Infectious Diseases Society of Taiwanand the Taiwan Society of Parasitology. The journal is an open access journal, committed to disseminating information on the latest trends and advances in microbiology, immunology, infectious diseases and parasitology. Articles on clinical or laboratory investigations of relevance to microbiology, infectious diseases, parasitology, and novel findings in all areas of immunology, encompassing both basic, clinical research and other related fields that are of interest to the medical profession are eligible for consideration. Article types considered include perspectives, review articles, original articles, brief reports and correspondence. The Editorial Board of the Journal comprises a dedicated team of local and international experts in the field of microbiology, immunology, infectious diseases and parasitology. All members of the Editorial Board actively guide and set the direction of the journal. With the aim of promoting effective and accurate scientific information, an expert panel of referees constitutes the backbone of the peer-review process in evaluating the quality and content of manuscripts submitted for publication. JMII is open access and indexed in SCIE, PubMed, MEDLINE, EMBASE, Scopus, AIDS & Cancer Reseach, CABI, BIOSIS Previews, Biological Abstracts, EBSCOhost, CancerLit, Reactions Weekly (online), Chemical Abstracts, HealthSTAR, Global Health, ProQuest.
From the journal's Aims & Scope
Research area (LetPub): IMMUNOLOGY-INFECTIOUS DISEASES
Editor-in-chief Po-Ren HsuehPublisher website
Editorial board by country: 5 in mainland China (about 6%); most named Taiwan, China 68, Mainland China 5, United States 3, Japan 1 (77 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology11%
- Antibiotic Use and ResistanceImmunology and Microbiology6.1%
- Pneumonia and Respiratory InfectionsMedicine5.9%
- Antimicrobial Resistance in StaphylococcusMedicine5.8%
- Nosocomial Infections in ICUMedicine5.7%
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology4.8%
- Respiratory viral infections researchMedicine4.7%
- Tuberculosis Research and EpidemiologyMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
| Minor | Infectious Diseases | Zone 3 |
| Minor | Microbiology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Immunology | Zone 3 |
| Minor | Infectious Diseases | Zone 3 |
| Minor | Microbiology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Immunology | Zone 3 |
| Minor | Infectious Diseases | Zone 3 |
| Minor | Microbiology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCASPublisher website
Other: ProQuest, AIDS & Cancer Reseach, CABI, BIOSIS Previews, Biological Abstracts, EBSCOhost, CancerLit, Reactions Weekly (online), HealthSTAR, Global Health
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.72LetPub ·
- Impact factor (publisher)
- 3.8Publisher website ·
- CiteScore 2026-06
- 7.8LetPub ·
- CiteScore (publisher)
- 7.8Publisher website ·
- SJR 2026-06
- 1.07LetPub ·
- SNIP 2026-06
- 1.18LetPub ·
- h-index
- 48LetPub ·
- h-index
- 89OpenAlex ·
- i10-index
- 1,263OpenAlex ·
- 2-year mean citedness
- 3.32OpenAlex ·
- Self-citation rate
- 7.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 89LetPub ·
Articles by year OpenAlex count · 2,772 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 66 | 66 | 3 |
| 2025 | 134 | 134 | 302 |
| 2024 | 112 | 112 | 732 |
| 2023 | 130 | 130 | 1,283 |
| 2022 | 109 | 109 | 1,819 |
| 2021 | 152 | 152 | 2,163 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
179 daysMedian, submission to acceptance · P25–P75 124 days – 245 days
- Acceptance to online
- median 4 days (113 articles)
- Submission to online
- median 185 days
- Sample
- 113 articles with submission and acceptance dates (250 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 95%LetPub ·
- First decision after review
- 80 daysPublisher website ·
- Submission to acceptance
- 170 daysPublisher website ·
- Submission to publication (journal-reported)
- about 45 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,000 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,000 / EUR 1,870 / GBP 1,600 / JPY 248,060 | — | — | |
| LetPub | USD 2,000 | Yes | — | |
| Publisher website | USD 2,000 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 3–5
- Manuscript length
- ≤ 1,000 words
- Reference style
- Numbered, in order of citation
- Cover letter
- Required
Article types accepted5
- correspondence5. Correspondence Correspondences include letter to Editor, and comments that respond to a recently published article in JMII or address an issue of interest to…Length not stated
- original articles3. Original Articles These articles typically include randomized trials, intervention studies, studies of screening and diagnostic tests, laboratory and animal …Length not stated
- perspectives1. Perspectives These are comments on recent news or groundbreaking work and should provide a short review of the current state of research and explain the impo…Length not stated
- review articles2. Review Articles These should aim to provide the reader with a balanced overview of an important and topical subject in the field, and should be systematic an…Length not stated
- short communications4. Short Communications Short Communications should present unusual aspects of common problems or novel perspectives upon, or solutions to, clinically relevant …Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Preprints
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Author contributions
For transparency, we require corresponding authors to provide co-author contributions to the manuscript using the relevant CRediT roles. The CRediT taxonomy includes 14 different roles describing each contributor's specific contribution to the scholarly output. The roles are: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration;…
Source ↗Publisher website ·- Conflicts of interest Disclosure of Conflicts of Interest
A conflict of interest occurs when an individual's objectivity is potentially compromised by a desire for financial gain, prominence, professional advancement or a successful outcome. JMII Editors strive to ensure that what is published in the Journal is as balanced, objective and evidence-based as possible. Since it can be difficult to distinguish between an actual conflict of interest and a perc…
Source ↗Publisher website ·- Data availability
Data availability statement encouraged. Model summary
To foster transparency, we encourage you to state the availability of your data in your submission.
Source ↗Publisher website ·- Publication ethics
Human/animal research requires approval letter from relevant review committee. Model summary
Articles covering the use of human or animal samples in research, or human or animal experiments must be accompanied by a letter of approval from the relevant review committee or authoritie
Source ↗Publisher website ·- License & copyright Copyright
Copyright transfer via Journal Publishing Agreement upon acceptance. Model summary
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Author rightsAs an author you (or your employer or institution) have certain rig…
Source ↗Publisher website ·- Open access Open Access
All articles will be available Open Access on ScienceDirect. Permitted (re)use is that outlined by the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) license, which states that for non-commercial purposes, others may distribute and copy the article, and include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or mod…
Source ↗Publisher website ·- Peer review Peer review
Double anonymized review process; papers sent to minimum of two independent expert reviewers. Model summary
This journal operates a double anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…
Source ↗Publisher website ·- Plagiarism
Articles may be checked by Crossref Similarity Check and other originality software. Model summary
To verify compliance, your article may be checked by Crossref Similarity Check and other originality or duplicate checking software.
Source ↗Publisher website ·- Preprints Preprint references
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Taiwan LLC
- Country or region
- TAIWAN
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1998
- ISSN
- 1684-1182
- Electronic ISSN
- 1995-9133
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Microbiology Immunology and Infection
What CAS zone is Journal of Microbiology Immunology and Infection in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Microbiology Immunology and Infection is in Zone 3 of Medicine, and in Zone 3 of the minor category Immunology / Infectious Diseases / Microbiology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Microbiology Immunology and Infection?
The latest impact factor listed by LetPub is 3.72; CiteScore 7.8, h-index 89.
How long does peer review take at Journal of Microbiology Immunology and Infection?
Based on the dates recorded on 113 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 179 days (interquartile range 124–245 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 95%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Microbiology Immunology and Infection?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–5; Manuscript length: ≤ 1,000 words; Reference style: Numbered, in order of citation; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Microbiology Immunology and Infection based?
Of the 77 board members whose country the journal's board page names, 5 (about 6%) are in mainland China; the countries named most often are Taiwan, China (68), Mainland China (5) and United States (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Microbiology Immunology and Infection?
According to LetPub and DOAJ records, Journal of Microbiology Immunology and Infection is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, PubMed, Embase and CAS; that list has not been checked against each database.
Is Journal of Microbiology Immunology and Infection open access, and what is the APC?
Journal of Microbiology Immunology and Infection is a fully open-access journal. APC about USD 2,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .